Millbrae, CA, United States of America

Ivan Chan

USPTO Granted Patents = 1 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **The Innovative Contributions of Ivan Chan in Immunotherapy**

Introduction

Ivan Chan, a trailblazing inventor based in Millbrae, California, has made notable contributions to the field of immunotherapy. With a singular patented innovation under his name, Chan's work promises to impact cancer treatment significantly. His dedication to advancing medical science is evidenced by his efforts in developing cutting-edge therapies that harness the body's immune system.

Latest Patents

Ivan Chan holds a patent titled "CD19-directed chimeric antigen receptors and uses thereof in immunotherapy." This patent describes immune cell-based compositions that incorporate CD19-directed chimeric antigen receptors. Notably, certain embodiments of the technology involve a humanized anti-CD19 binder, which enhances the expression of the CAR (chimeric antigen receptor) in immune cells such as natural killer (NK) cells. Furthermore, the patent details methods of utilizing these CAR-expressing immune cells in the realm of immunotherapy, showcasing the significant therapeutic potential in targeting CD19, a marker present in many B-cell malignancies.

Career Highlights

Ivan Chan's career has been marked by significant contributions to the biopharmaceutical industry. Currently, he is employed at Nkarta, Inc., where he collaborates on pioneering research focused on innovative cell therapies. His work centers around enhancing the efficacy of immune cells to create more effective treatments for cancer patients.

Collaborations

Throughout his career, Chan has worked alongside esteemed colleagues such as James Barnaby Trager and Luxuan Guo Buren. These collaborations reflect a commitment to driving forward the research and development of next-generation immunotherapeutic strategies. Together, they strive to unlock new therapeutic avenues for patients battling cancer.

Conclusion

Ivan Chan's innovative spirit and dedication to advancing immunotherapy are evident in his pioneering patent and collaborative efforts. With his significant contributions to the field of medicine, Chan continues to pave the way for new and effective cancer treatments that harness the power of the immune system. His work has the potential to change the landscape of cancer therapy and inspire future innovations in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…